Induction of B1 receptors in streptozotocin diabetic rats: Possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation

Canadian Journal of Physiology and Pharmacology

Volumn 80, Issue 4, 2002, Pages 328-333

  Mage, Marilyne ^a   Pécher, Christiane ^a   Neau, Eric ^a   Cellier, Eric ^a   Dos Reiss, Marina L ^a   Schanstra, Joost P ^a   Couture, Réjean ^a   Bascands, Jean Loup ^a   Girolami, Jean Pierre ^a  

^a CHU RANGUEIL   (France)

Author keywords

Converting enzyme inhibitor; ERK 1 and 2 phosphorylation; Kidney; Kinin receptors; Type 1 diabetes

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; LOSARTAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; STREPTOZOCIN; BRADYKININ RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD PRESSURE MONITORING; BODY WEIGHT; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG MECHANISM; ENZYME PHOSPHORYLATION; GLOMERULUS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; REDUCTION; STREPTOZOCIN DIABETES; WEIGHT REDUCTION; WESTERN BLOTTING; ANIMAL; ARTICLE; BIOSYNTHESIS; DRUG ANTAGONISM; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; HYPERGLYCEMIA; KIDNEY GLOMERULUS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B1; RECEPTORS, BRADYKININ;

EID: 0036011346     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y02-024     Document Type: Conference Paper

References (20)

1. Bradykinin-induced inhibition of cell proliferation and tyrosine kinase activity
2. Evidence for existence of two distinct bradykinin receptors on rat mesangial cells
3. Regulation of B(2)-kinin receptors by glucose in vascular smooth muscle cells
4. Pharmacological characterization of the cardiovascular responses elicited by kinin B(1) and B(2) receptor agonists in the spinal cord of streptozotocin-diabetic rats
5. Bradykinin stimulates the Erk-Elk-1, Fos/AP-1 patway in mesangial cells
6. Insulin-like growth factor I induces mesangial proliferation and increases mRNA and secretion of collagen
7. Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complication of diabetes
8. Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetes
9. Effect of diabetes and insulin on insulin on kallikrein and renin genes in the kidney
10. Kinin, a mediator of of diabetes-induced glomerular hyperfiltration
11. Bradykinin induces tubulin phosphorylation and nuclear translocation of MAP kinase in mesangial cells
12. Effect of glucose on stress-activated protein kinase activity in mesangial cells and diabetic
13. The effect of bradykinin on the oxidative state of rats with acute hyperglycaemia
14. Kinin receptors in the diabetic mouse
15. The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts
16. Captopril-induced reduction of serum levels of transforming growth factor-B1 correlates with long-term renoprotection in insulin-dependent diabetic patients
17. Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats
18. Angiotensin converting enzyme inhibitors in the prevention of diabetic renal diseases
19. Effects of B1 and B2 kinin receptor antagonists in diabetic mice